It is well established that TNBC tumors exhibit a tumor microenvironment (TME) enriched with immune cells, characterized by high levels of sTILs, PD-L1-positivity and up-regulated immune gene signatures [16, 17, 23, 24]. This evidence concerns the gene CD274 and neoplasm.